Patents Represented by Attorney Ram W. Sabnis
  • Patent number: 8334363
    Abstract: Oxidized and maleated compositions, such as oxidized and maleated tall oil compositions, can be prepared and used in a variety of industrial applications, including as emulsifiers and corrosion inhibitors.
    Type: Grant
    Filed: January 31, 2008
    Date of Patent: December 18, 2012
    Assignee: Georgia-Pacific Chemicals LLC
    Inventors: Phillip W. Hurd, Gary D. Fultz, Brett A. Neumann, John B. Hines
  • Patent number: 8299154
    Abstract: The present invention relates to a non-thermosetting composition made by reacting epichlorohydrin and a primary amine, to the use of that composition for making thermosetting (curable) adhesives suitable for bonding composites, to a method of preparing composites using the thermosetting (curable) adhesives, and to the related composites bonded with the thermosetting (curable) adhesives.
    Type: Grant
    Filed: March 5, 2010
    Date of Patent: October 30, 2012
    Assignee: Georgia-Pacific Chemicals LLC
    Inventors: Bobby L. Williamson, Richard M. Rammon
  • Patent number: 8257524
    Abstract: Aspects of this disclosure relate to a method of manufacturing wallboard which includes providing a first layer of facing material, creasing the first layer facing material intermittently to create a series of creased portions, providing a gypsum slurry on the first layer of facing material and providing a second layer of facing material over the gypsum slurry. Further, creasing the first layer of facing material intermittently can include intermittently creasing the first layer of facing material in a substantially linear fashion extending in a first direction of the first layer of facing material so that the first layer of facing material exhibits a linear series of creased portions extending in the first direction of the first layer of facing material and a series of portions that are not creased extending in the first direction of the first layer of facing material.
    Type: Grant
    Filed: November 7, 2008
    Date of Patent: September 4, 2012
    Assignee: Georgia-Pacific Gypsum LLC
    Inventor: Chad Andrew Frank
  • Patent number: 8257554
    Abstract: A thermosetting urea-formaldehyde (UF) resin composition containing a rheological-enhancing amount of a thickening agent, the use of the resin composition for formulating an adhesive binder for preparing fiber mats and the fiber mats made using the adhesive binder, wherein improved mat properties and faster cure speeds can be obtained.
    Type: Grant
    Filed: November 17, 2006
    Date of Patent: September 4, 2012
    Assignee: Georgia-Pacific Chemicals LLC
    Inventors: Mark Poggi, Kelly Shoemake
  • Patent number: 8252866
    Abstract: The present invention relates to polysaccharides that have been modified by providing azetidinium functionality thereto. Such functionality can be provided by crosslinking a polysaccharide with a resin having azetidinium functional groups. In one or more aspects, the polysaccharide can comprise one or more of starch, guar gum, alginate or derivatives thereof. Polysaccharides having azetidinium functionality according to the present invention are suitable for multiple uses. Such uses include, but are not limited to, removal of one or more solid materials from a liquid, beneficiation of an ore, removal of metallic ions from a liquid; providing oil from bitumen; and removal of mercury from synthetic gypsum. Other uses of the functionalized polysaccharides of the present invention include hydroseeding, dust control and erosion control.
    Type: Grant
    Filed: October 17, 2008
    Date of Patent: August 28, 2012
    Assignee: Georgia-Pacific Chemicals LLC
    Inventors: Michael J. Bush, John B. Hines, James T. Wright
  • Patent number: 8252427
    Abstract: The invention comprises an aqueous phenol-formaldehyde resole resin liquid fortified with powdered (e.g., spray dried) phenol-formaldehyde resole resin, preparing wood composites, particularly oriented strand board (OSB), waferboard, particleboard, medium density fiber board, and hardboard, using the solids-fortified liquid resin, and related wood composites bonded with the solids-fortified resin.
    Type: Grant
    Filed: April 15, 2011
    Date of Patent: August 28, 2012
    Assignee: Georgia-Pacific Chemicals LLC
    Inventors: Robert A. Breyer, James H. Knight, Daniel C. Yeager, Herbert J. Kennedy, Harmon E. Brehmer, Jr.
  • Patent number: 8246781
    Abstract: A creping adhesive comprising a PAE composition comprising a reactive, light crosslinked polyamidoamine-epichlorohydrin polymer (PAE-type polymer) optionally in combination with a reactive modifier and the corresponding method for of creping cellulosic fiber webs with the adhesive.
    Type: Grant
    Filed: March 1, 2011
    Date of Patent: August 21, 2012
    Assignee: Georgia-Pacific Chemicals LLC
    Inventors: Clay E. Ringold, Karla D. Favors, Dexter C. Johnson, David F. Townsend, Thomas L. Wright, Cornel Hagiopol
  • Patent number: 8226848
    Abstract: The present invention relates to a method for inhibiting the formation or accumulation of ice on a solid surface and for reducing the salt out temperatures.
    Type: Grant
    Filed: September 22, 2011
    Date of Patent: July 24, 2012
    Assignee: Georgia-Pacific Chemicals LLC
    Inventors: Pablo G. Dopico, Kurt D. Gabrielson, John B. Hines, Brian L. Swift, Dennis L. Kennedy
  • Patent number: 8221542
    Abstract: The present invention describes a fire resistant building material composition, useful for example as a fire door core and to a method of making this composition. The building material of the present invention is prepared from an aqueous mixture of predominately expanded perlite, a small amount of a binder component consisting essentially of calcined gypsum and an organic binder, and optionally a fibrous reinforcement.
    Type: Grant
    Filed: December 13, 2007
    Date of Patent: July 17, 2012
    Assignee: Georgia-Pacific Gypsum LLC
    Inventor: Hubert C. Francis
  • Patent number: 8101590
    Abstract: This invention provides compounds of Formula I having the structure where R1, R2, R3 and A are defined in the specification or a pharmaceutically acceptable salt thereof useful as antibacterial agents. Compounds according to Formula (II): where Q, R4, R5, R6 and R10 and A are defined in the specification are useful as chemical intermediates.
    Type: Grant
    Filed: August 31, 2006
    Date of Patent: January 24, 2012
    Assignee: Wyeth LLC
    Inventors: Phaik-Eng Sum, Tarek Suhayl Mansour, David Brian How, Darrin William Hopper, Matthew Douglas Vera, Joshua James Sabatini, Jaechul Shim
  • Patent number: 8063041
    Abstract: The present disclosure relates to polymorphic Form D of bazedoxifene acetate, pharmaceutical compositions and methods of treatment using the same, and methods of preparing the same.
    Type: Grant
    Filed: June 22, 2010
    Date of Patent: November 22, 2011
    Assignee: Wyeth LLC
    Inventors: Paolo Andreella, Roberto Brescello, Ivan Michieletto, Mauro Maffini, Nicola Catozzi, Andrea Nicoli, Paolo Fornasari, Massimo Verzini, Livius Cotarca, Franco Brazzarola
  • Patent number: 8017144
    Abstract: The present invention is directed to an improved system for controlled release of a bone growth promoting compound and to a flowable composition for its formation. The flowable composition is composed of a bone growth promoting compound, a thermoplastic polymer and an organic solvent. The flowable composition is capable of forming a biodegradable and/or bioerodible microporous, solid polymer matrix. The matrix is useful as an implant in patients (humans and animals) for delivery of a bone growth promoting compound to certain tissues.
    Type: Grant
    Filed: October 24, 2008
    Date of Patent: September 13, 2011
    Assignee: Pfizer Inc.
    Inventors: Francis Dumont, Richard L. Dunn, Scott A. Jeffers, Richard W. Korsmeyer, Mei Li, Vishwas M. Paralkar, Mingxing Zhou
  • Patent number: 7998965
    Abstract: The present invention relates to modulators of metalloproteinase activity.
    Type: Grant
    Filed: May 14, 2009
    Date of Patent: August 16, 2011
    Assignee: Wyeth LLC
    Inventors: Phaik-Eng Sum, Jerauld Stanley Skotnicki, Steve Yik-Kai Tam, Tarek Suhayl Mansour, David Brian How, Joshua James Sabatini, Jason Shaoyun Xiang, Eric Feyfant
  • Patent number: 7998978
    Abstract: The present invention relates to compounds of formula (I), or a pharmaceutically acceptable salt or solvate thereof, wherein: R1, R2, Z1, t, and ring A are as defined in the specification. The invention also relates to pharmaceutical compositions comprising the compounds of formula (I) and methods of treating a condition that is mediated by the modulation of JNK, such as diabetes, the method comprising administering to a mammal an effective amount of a compound of formula (I).
    Type: Grant
    Filed: April 19, 2007
    Date of Patent: August 16, 2011
    Assignee: Pfizer Inc.
    Inventors: Liming Huang, Song Liu, Elizabeth A. Lunney, Simon P. Planken
  • Patent number: 7994333
    Abstract: The present invention relates to the field of anti-inflammatory substances, and more particularly to novel compounds that act as antagonists of the mammalian adhesion proteins known as selectins. In some embodiments, methods for treating selectin mediated disorders are provided which include administration of compound of Formula I: wherein the constituent variables are defined herein.
    Type: Grant
    Filed: November 7, 2008
    Date of Patent: August 9, 2011
    Assignee: Wyeth LLC
    Inventors: Neelu Kaila, Silvano L. Debarnardo, Kristin M. Janz, Raymond T. Camphausen, Patricia Ward Bedard, Adrian Huang
  • Patent number: 7981912
    Abstract: The invention relates to indole acetic acid compounds which function as antagonists of the CRTH2 receptor. The invention also relates to the use of these compounds to inhibit the binding of prostaglandin D2 and its metabolites or certain thromboxane metabolites to the CRTH2 receptor and to treat disorders responsive to such inhibition.
    Type: Grant
    Filed: September 24, 2009
    Date of Patent: July 19, 2011
    Assignee: Wyeth LLC
    Inventors: Youssef L. Bennani, Lawrence Nathan Tumey, Elizabeth Ann Gleason, Michael Joseph Robarge
  • Patent number: 7947712
    Abstract: The present invention relates to 8-Hydroxyquinoline Compounds; compositions comprising an 8-Hydroxyquinoline Compound; and methods for treating or preventing a metalloproteinase-related disorder, such as, an arthritic disorder, osteoarthritis, malignant neoplasm, rheumatoid arthritis, asthma, chronic obstructive pulmonary disease, atherosclerosis, age-related macular degeneration, myocardial infarction, a corneal ulceration, an ocular surface disease, hepatitis, an aortic aneurysm, tendonitis, a central nervous system disorder, abnormal wound healing, angiogenesis, restenosis, cirrhosis, multiple sclerosis, glomerulonephritis, graft versus host disease, diabetes, an inflammatory bowel disease, shock, invertebral disc degeneration, stroke, osteopenia or a periodontal disease or comprising administering an effective dose of an 8-Hydroxyquinoline Compound to a mammal in need thereof.
    Type: Grant
    Filed: August 23, 2007
    Date of Patent: May 24, 2011
    Assignee: Wyeth LLC
    Inventors: Matthew G. Bursavich, Sabrina Lombardi, Adam M. Gilbert, Leif Mark Laakso, Gulnaz Khafizova, David Brian How, Joshua James Sabatini, Phaik-Eng Sum, Jeremy Clemens
  • Patent number: 7923446
    Abstract: The present invention relates to biaryl sulfonamides and their use as, for example, metalloproteinase inhibitors.
    Type: Grant
    Filed: May 31, 2007
    Date of Patent: April 12, 2011
    Assignee: Wyeth LLC
    Inventors: Jason Shaoyun Xiang, Steve Yikkai Tam, Yonghan Hu, Phaik-Eng Sum, David Brian How, Darrin William Hopper, Matthew Douglas Vera, Joshua James Sabatini, Thomas Saltmarsh Rush, III, Elisabeth Ann Morris, Katy Evangelia Georgiadis
  • Patent number: 7919490
    Abstract: The present invention provides novel purinones and purines useful for the prevention and treatment of autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection.
    Type: Grant
    Filed: October 4, 2007
    Date of Patent: April 5, 2011
    Assignee: Wyeth LLC
    Inventors: Irina Neagu, David Diller, Celia Kingsbury, Adolph C. Bohnstedt, Michael J. Ohlmeyer, Vidyadhar Paradkar, Nasrin Ansari
  • Patent number: 7915268
    Abstract: The present invention provides novel purines useful for the prevention and treatment of autoimmune diseases, inflammatory diseases, mast cell mediated disease and transplant rejection.
    Type: Grant
    Filed: October 4, 2007
    Date of Patent: March 29, 2011
    Assignee: Wyeth LLC
    Inventors: Yingchun Lu, Celia Kingsbury, Adolph Bohnstedt, Michael Ohlmeyer, Vidyadhar Paradkar